Tag Archives: Western Australia

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann Plants Second Crop in Chile

AusCann Plants Second Crop in Chile

CARABOODA, Western Australia, Dec. 18, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce that its 50:50 Chilean joint venture, DayaCann, has commenced planting of its second medicinal cannabis crop, following the grant of its cultivation licence as announced on 22 November 2017.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

Final Operational Licence Now in Place

CARABOODA, Western Australia, Dec. 7, 2017 /Weed Wire/ – The licence was granted under the Narcotic Drugs Act 1967 to Tasmanian Alkaloids, AusCann’s strategic partner and allows for the joint manufacture and supply of medical cannabis products in Australia.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann Welcomes The Passing of Medicinal Cannabis Legislation Amendment

CARABOODA, Western Australia, Oct. 20, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) welcomes the passing of the Medicinal Cannabis Legislation Amendment (Securing Patient Access) Bill 2017 (the Bill) in the Senate yesterday.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann – Tasmanian Alkaloids Licences Secured

CARABOODA, Western Australia, July 11, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce its strategic partner Tasmanian Alkaloids Pty Ltd has been granted a medicinal cannabis licence and a research and development licence from the Office of Drug Control.

AusCann

AusCann Group Provides Quarterly Overview

CARABOODA, Western Australia, April 28, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) has today announced its appendix 4C for the 3 month period ended 31 March 2017 and is pleased to provide an overview of its activities for the quarter.


Top